Magellan Health (MGLN) Tops Q4 EPS Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Jefferies Reiterates Buy on Magellan Health (MGLN) Following 4Q - PT to $77
March 1, 2016 9:35 AM ESTJefferies reiterated a Buy rating on Magellan Health Services (NASDAQ: MGLN), and raised the price target to $77.00 (from $73.00), following the company's 4Q.
Analyst David Styblo commented, "We still believe MGLN is undervalued despite today's surge (+8% vs S&P's -0.3%). The Healthcare and Pharmacy Solution... More
